---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-066558"
form_type: "8-K"
ticker: null
cik: "0001403708"
company_name: "Evoke Pharma Inc"
filed_at: "2023-11-29T23:59:59+00:00"
generated_at: "2026-06-07T20:14:39.874408+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Evoke Pharma faces Nasdaq delisting; hearing set for March 7, 2024

## Summary
- Received Nasdaq notice on Nov 21 for non-compliance with Minimum Stockholders' Equity Requirement of $2.5M.
- Hearing before Nasdaq Hearings Panel scheduled for March 7, 2024; delisting action stayed pending outcome.
- Company exploring options including raising capital, but no assurance of regaining compliance.
- Non-compliance risk could lead to transfer to OTC markets if delisted.

## SEC filing metadata
- accession: 0000950170-23-066558
- form_type: 8-K
- cik: 0001403708
- company_name: Evoke Pharma Inc
- filed_at: 2023-11-29T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1403708/000095017023066558/0000950170-23-066558-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1403708/000095017023066558/evok-20231127.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-066558
- JSON: https://secwatch.observer/filing/0000950170-23-066558.json
- Plain text: https://secwatch.observer/filing/0000950170-23-066558.txt

## Key facts
- Listing & Compliance Notices
  Evoke Pharma Inc received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: stockholders equity
  - Rules: 5550(b)(1)
  source text: November 21, 2023, Evoke Pharma, Inc. (the “Company”) received a written notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) that, due to the Company’s non-compliance with Nasdaq Listing Rule 5550(b)(1) (the “Minimum Stockholders’ Equity Requirement”),which requires listed companies to maintain stockholders’ equity of at least $2.5 million, the Company was subject to delisting unless it timely requested a hearing before the Nasdaq Hearings Panel (the “Hearings Panel”). On November 27, 2023, Nasdaq notified the Company that the hearing was scheduled for M
  evidence_url: https://www.sec.gov/Archives/edgar/data/1403708/000095017023066558/0000950170-23-066558-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.